FI965165A0 - Stabiloidut, steriileissä olosuhteissa suodattavat nanopartikkelit - Google Patents

Stabiloidut, steriileissä olosuhteissa suodattavat nanopartikkelit

Info

Publication number
FI965165A0
FI965165A0 FI965165A FI965165A FI965165A0 FI 965165 A0 FI965165 A0 FI 965165A0 FI 965165 A FI965165 A FI 965165A FI 965165 A FI965165 A FI 965165A FI 965165 A0 FI965165 A0 FI 965165A0
Authority
FI
Finland
Prior art keywords
sterile conditions
stabilized
filterable nanoparticles
water
nanoparticles
Prior art date
Application number
FI965165A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI965165A (fi
Inventor
Michel Laborie
Joel Vacus
Thierry Verrecchia
Marie-Christine Bissery
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of FI965165A0 publication Critical patent/FI965165A0/fi
Publication of FI965165A publication Critical patent/FI965165A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/773—Nanoparticle, i.e. structure having three dimensions of 100 nm or less
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/788—Of specified organic or carbon-based composition
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/70—Nanostructure
    • Y10S977/788—Of specified organic or carbon-based composition
    • Y10S977/795—Composed of biological material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/906—Drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Filtering Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Materials For Medical Uses (AREA)
FI965165A 1994-06-22 1996-12-20 Stabiloidut, steriileissä olosuhteissa suodattavat nanopartikkelit FI965165A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9407628A FR2721510B1 (fr) 1994-06-22 1994-06-22 Nanoparticules filtrables dans des conditions stériles.
PCT/FR1995/000813 WO1995035101A1 (fr) 1994-06-22 1995-06-20 Nanoparticules stabilisees et filtrables dans des conditions steriles

Publications (2)

Publication Number Publication Date
FI965165A0 true FI965165A0 (fi) 1996-12-20
FI965165A FI965165A (fi) 1996-12-20

Family

ID=9464490

Family Applications (1)

Application Number Title Priority Date Filing Date
FI965165A FI965165A (fi) 1994-06-22 1996-12-20 Stabiloidut, steriileissä olosuhteissa suodattavat nanopartikkelit

Country Status (21)

Country Link
US (1) US6146663A (es)
EP (1) EP0766555B1 (es)
JP (1) JP3806937B2 (es)
CN (1) CN1151114A (es)
AT (1) ATE174791T1 (es)
AU (1) AU2797995A (es)
BR (1) BR9508363A (es)
CA (1) CA2192712A1 (es)
CZ (1) CZ377296A3 (es)
DE (1) DE69506867T2 (es)
DK (1) DK0766555T3 (es)
ES (1) ES2126905T3 (es)
FI (1) FI965165A (es)
FR (1) FR2721510B1 (es)
HU (1) HUT76549A (es)
MX (1) MX9606490A (es)
NO (1) NO965458D0 (es)
PL (1) PL317893A1 (es)
SK (1) SK166696A3 (es)
WO (1) WO1995035101A1 (es)
ZA (1) ZA955047B (es)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070092563A1 (en) * 1996-10-01 2007-04-26 Abraxis Bioscience, Inc. Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
EP2272504A3 (en) * 1997-06-27 2014-02-26 Abraxis BioScience, LLC Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
US8853260B2 (en) 1997-06-27 2014-10-07 Abraxis Bioscience, Llc Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
CN1406140A (zh) 2000-02-28 2003-03-26 吉倪塞思公司 纳米胶囊包封系统与方法
CA2309575A1 (en) * 2000-05-26 2001-11-26 James E. Guillet Internally cross-linked macromolecules
US9700866B2 (en) 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
US7193084B2 (en) * 2000-12-22 2007-03-20 Baxter International Inc. Polymorphic form of itraconazole
US8067032B2 (en) 2000-12-22 2011-11-29 Baxter International Inc. Method for preparing submicron particles of antineoplastic agents
US6869617B2 (en) * 2000-12-22 2005-03-22 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
US20050048126A1 (en) 2000-12-22 2005-03-03 Barrett Rabinow Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
US6635173B2 (en) * 2000-12-28 2003-10-21 Cohesive Technologies, Inc. Multi column chromatography system
ES2178961B1 (es) * 2001-03-06 2004-07-01 Instituto Cientifico Y Tecnologico De Navarra, S.A. Fabricacion de nanoparticulas a base del copolimero de metil vinil eter y anhidrido maleico para la administracion de farmacos de naturaleza hidrofilica, en particular de bases puricas y pirimidinicas.
EP1401399A2 (en) * 2001-06-22 2004-03-31 Pfizer Products Inc. Pharmaceutical compositions containing polymer and drug assemblies
JP2005504090A (ja) 2001-09-26 2005-02-10 バクスター・インターナショナル・インコーポレイテッド 分散体および溶媒相または液相の除去によるサブミクロンサイズ−ナノ粒子の調製
US20060003012A9 (en) 2001-09-26 2006-01-05 Sean Brynjelsen Preparation of submicron solid particle suspensions by sonication of multiphase systems
US7112340B2 (en) * 2001-10-19 2006-09-26 Baxter International Inc. Compositions of and method for preparing stable particles in a frozen aqueous matrix
US20040038303A1 (en) * 2002-04-08 2004-02-26 Unger Gretchen M. Biologic modulations with nanoparticles
US6960378B1 (en) 2002-06-27 2005-11-01 Rensselaer Polytechnic Institute Tubular microstructures via controlled nanoparticle assembly
WO2004084870A1 (en) * 2003-03-28 2004-10-07 Sigmoid Biotechnologies Limited Solid oral dosage form containing seamless microcapsules
EP1711163A2 (en) * 2004-02-05 2006-10-18 Baxter International Inc. Dispersions prepared by use of self-stabilizing agents
EP1802287A2 (en) * 2004-09-27 2007-07-04 Sigmoid Biotechnologies Limited Minicapsule formulations
US7901711B1 (en) * 2006-04-17 2011-03-08 Gp Medical, Inc. Nanoparticles for protein/peptide delivery and delivery means thereof
EP1837015A1 (en) * 2004-12-17 2007-09-26 Mitsubishi Chemical Corporation Novel core-shell structure
GB0501833D0 (en) * 2005-01-28 2005-03-09 Unilever Plc Carrier liquids and methods of production thereof
AU2007265452A1 (en) * 2006-06-26 2008-01-03 Mutual Pharmaceutical Company, Inc. Active agent formulations, methods of making, and methods of use
WO2008040799A2 (en) * 2006-10-06 2008-04-10 Boehringer Ingelheim International Gmbh Process for preparing instant forms of aqueous mixed micellar solutions as physiological buffer systems for use in the analysis of in vitro release
US20100068251A1 (en) * 2006-10-10 2010-03-18 Jina Pharmaceuticals, Inc. Aqueous Systems For The Preparation Of Lipid Based Pharmaceutical Compounds; Compositions, Methods, And Uses Thereof
CA2683407C (en) 2007-04-04 2016-09-20 Sigmoid Pharma Limited Pharmaceutical cyclosporin compositions
JP2010527285A (ja) * 2007-04-26 2010-08-12 シグモイド・ファーマ・リミテッド 複数のミニカプセルの製造
US20100239665A1 (en) * 2007-05-01 2010-09-23 Ivan Coulter Pharmaceutical nimodipine compositions
WO2008135828A2 (en) 2007-05-03 2008-11-13 Pfizer Products Inc. Nanoparticles comprising a drug, ethylcellulose, and a bile salt
WO2008135855A2 (en) 2007-05-03 2008-11-13 Pfizer Products Inc. Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and a nonionizable polymer
US8426467B2 (en) 2007-05-22 2013-04-23 Baxter International Inc. Colored esmolol concentrate
US8722736B2 (en) 2007-05-22 2014-05-13 Baxter International Inc. Multi-dose concentrate esmolol with benzyl alcohol
US8974827B2 (en) 2007-06-04 2015-03-10 Bend Research, Inc. Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
WO2008149230A2 (en) 2007-06-04 2008-12-11 Pfizer Products Inc. Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glycol succinate
WO2009038591A1 (en) * 2007-09-17 2009-03-26 Yale University Bile salt colloids and methods of making and using thereof
US9233078B2 (en) 2007-12-06 2016-01-12 Bend Research, Inc. Nanoparticles comprising a non-ionizable polymer and an Amine-functionalized methacrylate copolymer
EP2231169B1 (en) 2007-12-06 2016-05-04 Bend Research, Inc. Pharmaceutical compositions comprising nanoparticles and a resuspending material
US20100159010A1 (en) * 2008-12-24 2010-06-24 Mutual Pharmaceutical Company, Inc. Active Agent Formulations, Methods of Making, and Methods of Use
WO2010133609A2 (en) 2009-05-18 2010-11-25 Sigmoid Pharma Limited Composition comprising oil drops
CN102573802A (zh) 2009-08-12 2012-07-11 希格默伊德药业有限公司 包含聚合物基质和油相的免疫调节组合物
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
JP6679593B2 (ja) 2014-09-03 2020-04-15 ジーンセグエス，インコーポレイテッド 療法用ナノ粒子および関連する組成物、方法、およびシステム
BR112017009510A2 (pt) 2014-11-07 2017-12-19 Sigmoid Pharma Ltd composições compreendendo ciclosporina
EP3347794B1 (en) 2015-09-04 2023-07-19 Yale University Polymeric bile acid nanocompositions targeting the pancreas and colon

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3421468A1 (de) * 1984-06-08 1985-12-19 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
DE3586085D1 (de) * 1984-10-22 1992-06-25 Teijin Ltd Antitumor-4-hydroxy-2-zyklopentenonen.
US5025004A (en) * 1988-06-13 1991-06-18 Eastman Kodak Company Water-dispersible polymeric compositions
SE464743B (sv) * 1989-06-21 1991-06-10 Ytkemiska Inst Foerfarande foer framstaellning av laekemedelspartiklar
US5469854A (en) * 1989-12-22 1995-11-28 Imarx Pharmaceutical Corp. Methods of preparing gas-filled liposomes
JP2523926B2 (ja) * 1990-04-04 1996-08-14 松下電器産業株式会社 複合電話機
FR2660556B1 (fr) * 1990-04-06 1994-09-16 Rhone Poulenc Sante Microspheres, leur procede de preparation et leur utilisation.
FR2678168B1 (fr) * 1991-06-28 1993-09-03 Rhone Poulenc Rorer Sa Nanoparticules ayant un temps de capture par le dysteme reticulo endothelial allonge.
FR2678178A1 (fr) * 1991-06-28 1992-12-31 Rhone Poulenc Rorer Sa Procede de preparation de nanoparticules.
GB9300875D0 (en) * 1993-01-18 1993-03-10 Ucb Sa Nanocapsule containing pharmaceutical compositions

Also Published As

Publication number Publication date
HUT76549A (en) 1997-09-29
NO965458L (no) 1996-12-18
SK166696A3 (en) 1997-08-06
MX9606490A (es) 1997-03-29
CN1151114A (zh) 1997-06-04
PL317893A1 (en) 1997-04-28
JP3806937B2 (ja) 2006-08-09
EP0766555B1 (fr) 1998-12-23
JPH10501804A (ja) 1998-02-17
EP0766555A1 (fr) 1997-04-09
CA2192712A1 (fr) 1995-12-28
US6146663A (en) 2000-11-14
CZ377296A3 (en) 1997-04-16
FR2721510B1 (fr) 1996-07-26
ATE174791T1 (de) 1999-01-15
ZA955047B (en) 1996-02-09
DE69506867T2 (de) 1999-06-24
FI965165A (fi) 1996-12-20
WO1995035101A1 (fr) 1995-12-28
AU2797995A (en) 1996-01-15
BR9508363A (pt) 1997-11-04
DE69506867D1 (de) 1999-02-04
FR2721510A1 (fr) 1995-12-29
ES2126905T3 (es) 1999-04-01
HU9603533D0 (en) 1997-02-28
NO965458D0 (no) 1996-12-18
DK0766555T3 (da) 1999-08-23

Similar Documents

Publication Publication Date Title
FI965165A (fi) Stabiloidut, steriileissä olosuhteissa suodattavat nanopartikkelit
PT869776E (pt) Nanoparticulas estabilizadas e filtraveis em condicoes estereis
DE69535310D1 (de) Stabile Wasser-in-Öl Emulsionssysteme
BR0110505A (pt) Sistemas de lentes oftálmicas
ES551371A0 (es) Procedimiento para preparar una dispersion acuosa estable, congelada, de un copolimero y una droga insoluble en agua. (como desglose y con prioridad de la patente espanola no. 544.580, presentada el 26 de junio de 1985).
ATE290838T1 (de) Vorrichtung zur senkung des augeninnendruckes
ATE185489T1 (de) Polymere als kontrastmittel bei magnetischer resonanz
DE69616347D1 (de) O-Carboxymethylchitosan enthaltende Mittel und ihre Verwendung in Ophthalmika
DE69731237D1 (de) Verfahren zur verminderung von körpergeruch
MA23219A1 (fr) Emulsions aqueuses stables de tensio-actifs non ioniques
NZ516295A (en) Structured surfactant systems
ES2171950T3 (es) Producto acuoso, suavizante de la colada, con alto potencial zeta.
DE69621521T2 (de) Cyclodextrinderivate, ihre Herstellung und Verwendung zur Einbringung von hydrophoben Molekülen in strukturierten Tensidsystemen
DE60210085D1 (de) Stabilitätsverstärktes persäurebleichungssystem geeignet für gewebebehandlung
EP1219349A3 (de) Verwendung teilchenförmiger Polymerisate als Filterhilfsmittel für wässrige Flüssigkeiten
ES2118824T3 (es) Composiciones oftalmicas a base de acido poliacrilico.
Santander et al. Effects of" in situ" vitamin E on fibroblast differentiation and on collagen fibril development in the regenerating tendon.
KR900007438A (ko) 일본뇌염 백신 및 그의 제조방법

Legal Events

Date Code Title Description
FD Application lapsed